BROADFOOT JILL MARIE (Chief Financial Officer) sold 4.0% of their position (1.56K shares) of ATYR PHARMA INC on the open market
Open‑market sale worth $1.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/4/2026ACC: 0001193125-26-038002
Officer· Chief Financial Officer
Since Jul 2018
-1.56K
Net shares
Net seller
$1.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.75K acquired · 5.31K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
10.7%
2/3/2026
35.10K→38.85K
Common Stock
Direct
Shares
−1.56K
Price / share
$0.98
Trade value
$1.52K
% of position
4.0%
2/4/2026
38.85K→37.30K
Total
Net shares
+2.19K
Net value
-$1.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | M · Option Exercise | +3.75K | — | — | 10.7% | 35.10K | 38.85K |
| Common Stock Direct | 2/4/2026 | S · Sale | −1.56K | $0.98 | $1.52K | 4.0% | 38.85K | 37.30K |
| Total | +2.19K | -$1.52K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
0.00
Exercisable
—
2/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock3.75K shares | 2/3/2026 | M · Option Exercise | −3.75K | — | 0.00 |